OptiBiotix Health PLC OPTI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX5.85
- Day Range
- GBX5.83–5.90
- 52-Week Range
- GBX4.50–11.02
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 103.30M
- Market Cap
- GBX604.31M
- Volume/Avg
- 70,807 / 193,424
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.67
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 9
- Website
- https://www.optibiotix.com
Valuation
|
Metric
|
OPTI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.58 |
Price/Sales | 4.67 |
Price/Cash Flow | — |
Price/Earnings
OPTI
Financial Strength
|
Metric
|
OPTI
|
|---|---|
Quick Ratio | 5.23 |
Current Ratio | 6.83 |
Interest Coverage | — |
Quick Ratio
OPTI
Profitability
|
Metric
|
OPTI
|
|---|---|
Return on Assets (Normalized) | −32.99% |
Return on Equity (Normalized) | −42.47% |
Return on Invested Capital (Normalized) | −36.01% |
Return on Assets
OPTI
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|!zRJ#^@ | LOCK|G%tn | $128B | |||
| Moderna Inc
MRNA
| LOCK|W><dZ@ | LOCK|X$ | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|!%M$&%? | LOCK|kHN# | $76B | |||
| argenx SE ADR
ARGX
| LOCK|#gk&df | LOCK|hlY | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|b@<JG## | LOCK|$l | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|@JRM<$ | LOCK|<^%@# | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|?#n^ry$ | LOCK|vz<v | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|SBRRYn | LOCK|?Y | $24B | |||
| Incyte Corp
INCY
| LOCK|#d$ML%l | LOCK|xPf | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|KD??z@z | LOCK|G> | $15B |
United States